Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANNX compared with SLN: revenue, margins and what each company keeps, and the suppliers and customers both name
ANNX
Annexon, Inc.
Change
Mkt cap
Revenue
Revenue
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANNX
Annexon, Inc.
vs
SLN
Silence Therapeutics plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ANNX: latest quarter not drawable. SLN: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANNX, solid
SLN, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ANNX
0
None
Shared
0
No disclosed counterparties: ANNX.
Only SLN
2
AZN
AstraZeneca AB
customer
—
Hansoh Pharmaceutical
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
ANNX
Annexon, Inc.
Change
4.07
▲
+1.37%
· post 4.09
Mkt cap
$828.0M
Revenue
—
Revenue
—
SLN
Silence Therapeutics plc
Change
19.76
▼
−0.20%
· post 19.76
Closed
Oct 30 '26
Mkt cap
$933.1M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
vs
Compare
Closed
Oct 30 '26
ANNX
Annexon, Inc.
vs
SLN
Silence Therapeutics plc
4.07
▲
+1.37%
post 4.09
Price
19.76
▼
−0.20%
post 19.76
$828.0M
Mkt cap
$933.1M
—
Revenue
$422,000
Q1 FY26
—
Revenue
$559,000
FY25
Change
Change
ANNX
4.07
▲
+1.37%
vs
SLN
19.76
▼
−0.20%
Closed
Oct 30 '26